Investigating the Bioavailability of Broccoli Extract Supplements
Recruiting now · Not applicable
Conditions studied: Diet, Healthy
In brief
The goal of this clinical trial is to compare how much glucoraphanin and sulforaphane from 3 different versions of broccoli extract supplements is absorbed into the body and excreted in urine. This study involves generally healthy adults age 18-60 years. The supplements contain glucoraphanin and myrosinase enzyme, both naturally occurring in cruciferous vegetables. Once ingested, glucoraphanin is converted to the bioactive compound sulforaphane, which is thought to have numerous health benefits, including cancer prevention. Participants will: * consume 3 different versions of broccoli extract supplements (glucoraphanin will range from 35-70 mg) * complete 3 separate 24 hour study cycles * submit blood and urine samples for 24 hours * follow diet restrictions (no cruciferous vegetables or condiments or phytochemical/herbal supplements for 1 week prior to and during each study cycle)
Key facts
- Study ID
- NCT07564674
- Run by
- Oregon State University
- People needed
- 12
- Starts
- 2026-08-04
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2026-08-07
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy adults, 18-60 years of age
- Willing to stop taking herbal and phytochemical (plant-based extract or phytochemical) supplements for 1 week prior to and during each study cycle
- Willing to stop cruciferous vegetable intake 1 week prior to and during each study cycle
- Must be able to give written informed consent
You may not qualify if…
- Body Mass Index (BMI) <18.5 or >30.0 kg/m2
- Tobacco use, including e-cigarettes, or smoking of any substance (e.g. cannabis) in the past three months
- Pregnancy, breastfeeding, or planning to become pregnant before completing the study
- Engaging in vigorous exercise more than 7 hours per week
- Have a significant acute or chronic illness such as cardiovascular disease, kidney or liver disease, diabetes, thyroid disorder, or radiation or chemotherapy treatment for cancer within the past five years
- Use of medications to control cholesterol (e.g. statins, cholestyramine) or fat absorption (e.g. orlistat)
- Have had bariatric surgery (e.g. gastric bypass, gastric banding, sleeve gastrectomy, etc.), other gastrointestinal procedure (e.g. cholecystectomy) or disorders (e.g. Crohn's disease, celiac disease, ulcerative colitis)
- Allergic to broccoli, moringa, mustard, or maitake mushrooms
- Weighs less than 110 pounds
- Diagnosis of sickle cell disease
Where it is running
- Oregon State University — Corvallis, Oregon, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.